VEGFA and endophthalmitis: The incidence of endophthalmitis following intravitreal anti-vascular endothelial growth factor (anti-VEGF) injection was reported as 0.029–0.15% [40, 41] and following intravitreal TA injection was reported as 0.030–0.87% [42, 43].